Endurant Stent Graft approved in the EU

229

Medtronic’s Endurant Stent Graft was CE marked in July. The new device seeks to address those AAA patients whose aortas are highly angulated or whose aneurysms have short necks. Patients with these complex anatomies would previously have had no choice but watchful waiting or open surgical repair, in which the abdomen is opened and major organs temporarily moved in order to access the aorta. The Endurant Stent Graft System is an investigational device in the US, where it is limited to investigational use only.

Professor Hence Verhagen, Erasmus Medical Center, Rotterdam, The Netherlands, led the European clinical trial of the Endurant Stent Graft System which supported the CE mark: “This next-generation device has performed exceptionally well in the treatment of abdominal aortic aneurysms. The Endurant System has the potential to expand the applicability of EVAR to more AAA patients who have been considered especially difficult to treat.”

(Visited 11 times, 1 visits today)